bht-3021
Gene therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2006 (NCT00453375)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- InsulinImmunity, desensitized
INS immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bht-3021
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00453375 | Phase 1 | Oct 1, 2006 | Bayhill Therapeutics, University of Colorado, Denver, Walter and Eliza Hall Institute of Medical Research |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bayhill Therapeutics | For profit | 1 | 1 | 1 | 2006 |
| University of Colorado, Denver | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Walter and Eliza Hall Institute of Medical Research | Academic/Hospital | 1 | 0 | 1 | 2006 |
3 organizations
Page 1 / 1